Necroptosis inhibitor necrostatin-1 promotes cell protection and physiological function in traumatic spinal cord injury

Neuroscience

Volumn 266, Issue , 2014, Pages 91-101

  Wang, Y ^a   Wang, H ^a   Tao, Y ^a   Zhang, S ^a   Wang, J ^a   Feng, X ^a  

^a NORTHERN JIANGSU PEOPLE S HOSPITAL   (China)

Author keywords

Apoptosis; Cell protection; Necroptosis; Necrostatin 1; Physiological function; Spinal cord injury

Indexed keywords

CASPASE 3; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MALONALDEHYDE; NECROSTATIN 1; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE INHIBITOR; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; IMIDAZOLE DERIVATIVE; INDOLE DERIVATIVE; NECROSTATIN-1; NEUROPROTECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; MALE; NECROPTOSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT MODEL; SPINAL CORD INJURY; TASK PERFORMANCE; ANIMAL; CONVALESCENCE; DISEASE MODEL; DRUG EFFECTS; IMMUNOHISTOCHEMISTRY; METABOLISM; NECROSIS; NICK END LABELING; PATHOLOGY; SPINAL CORD INJURIES; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; IMIDAZOLES; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INDOLES; MALE; NECROSIS; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RECOVERY OF FUNCTION; SPINAL CORD INJURIES;

EID: 84895762964     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.02.007     Document Type: Article

References (33)

1. Bains M., Hall E.D. Antioxidant therapies in traumatic brain and spinal cord injury. Biochim Biophys Acta 2012, 1822:675-684.
2. Basso D.M., Beattie M.S., Bresnahan J.C. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 1995, 12:1-21.
3. Beattie M.S., Hermann G.E., Rogers R.C., Bresnahan J.C. Cell death in models of spinal cord injury. Prog Brain Res 2002, 137:37-47.
4. Bryden A.M., Ancans J., Mazurkiewicz J., McKnight A., Scholtens M. Technology for spinal cord injury rehabilitation and its application to youth. J Pediatr Rehabil Med 2012, 5:287-299.
5. Chavez-Valdez R., Martin L.J., Flock D.L., Northington F.J. Necrostatin-1 attenuates mitochondrial dysfunction in neurons and astrocytes following neonatal hypoxia-ischemia. Neuroscience 2012, 219:192-203.
6. David S., López-Vales R., Wee Yong V. Harmful and beneficial effects of inflammation after spinal cord injury: potential therapeutic implications. Handb Clin Neurol 2012, 109:485-502.
7. Degterev A., Hitomi J., Germscheid M., Ch'en I.L., Korkina O., Teng X., Abbott D., Cuny G.D., Yuan C., Wagner G., Hedrick S.M., Gerber S.A., Lugovskoy A., Yuan J. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 2008, 4:313-321.
8. Goldsmith H.S. The evolution of omentum transposition: from lymphedema to spinal cord, stroke and Alzheimer's disease. Neurol Res 2004, 26:586-593.
9. Hall E.D. Inhibition of lipid peroxidation in central nervous system trauma and ischemia. J Neurol Sci 1995, 134(Suppl):79-83.
10. He Y., Liu W., Koch L.G., Britton S.L., Keep R.F., Xi G., Hua Y. Susceptibility to intracerebral hemorrhage-induced brain injury segregates with low aerobic capacity in rats. Neurobiol Dis 2012, 49C:22-28.
11. Jaerve A., Müller H.W. Chemokines in CNS injury and repair. Cell Tissue Res 2012, 349:229-248.
12. Jia Z., Zhu H., Li J., Wang X., Misra H., Li Y. Oxidative stress in spinal cord injury and antioxidant-based intervention. Spinal Cord 2012, 50:264-274.
13. Karimi-Abdolrezaee S., Eftekharpour E. Stem cells and spinal cord injury repair. Adv Exp Med Biol 2012, 760:53-73.
14. Keane R.W., Davis A.R., Dietrich W.D. Inflammatory and apoptotic signaling after spinal cord injury. J Neurotrauma 2006, 23:335-344.
15. Liu W.M., Wu J.Y., Li F.C., Chen Q.X. Ion channel blockers and spinal cord injury. J Neurosci Res 2011, 89:791-801.
16. Liu P., Yao Y., Liu M.Y., Fan W.L., Chao R., Wang Z.G., Liu Y.C., Zhou J.H., Zhao J.H. Spinal trauma in mainland China from 2001 to 2007: an epidemiological study based on a nationwide database. Spine 2012, 37. [Phila Pa 1976].
17. Loo D.T. In situ detection of apoptosis by the TUNEL assay: an overview of techniques. Methods Mol Biol 2011, 682:3-13.
18. Lukens J.R., Vogel P., Johnson G.R., Kelliher M.A., Iwakura Y., Lamkanfi M., Kanneganti T.D. RIP1-driven autoinflammation targets IL-1α independently of inflammasomes and RIP3. Nature 2013, 498:224-227.
19. Marsala J., Orendácová J., Lukácová N., Vanický I. Traumatic injury of the spinal cord and nitric oxide. Prog Brain Res 2007, 161:171-183.
20. Moon Y.J., Lee J.Y., Oh M.S., Pak Y.K., Park K.S., Oh T.H., Yune T.Y. Inhibition of inflammation and oxidative stress by Angelica dahuricae radix extract decreases apoptotic cell death and improves functional recovery after spinal cord injury. J Neurosci Res 2012, 90:243-256.
21. Naujokat C. Role of ubiquitin ligases in neural stem and progenitor cells. Arch Immunol Ther Exp (Warsz) 2009, 57:177-188.
22. Redondo-Castro E., Torres-Espín A., García-Alías G., Navarro X. Quantitative assessment of locomotion and interlimb coordination in rats after different spinal cord injuries. J Neurosci Methods 2013, 213:165-178.
23. Sacerdote P., Franchi S., Moretti S., Castelli M., Procacci P., Magnaghi V., Panerai A.E. Cytokine modulation is necessary for efficacious treatment of experimental neuropathic pain. J Neuroimmune Pharmacol 2013, 8:202-211.
24. Spitzbarth I., Baumgärtner W., Beineke A. The role of pro- and anti-inflammatory cytokines in the pathogenesis of spontaneous canine CNS diseases. Vet Immunol Immunopathol 2012, 147:6-24.
25. Sun L., Wang H., Wang Z., He S., Chen S., Liao D., Wang L., Yan J., Liu W., Lei X., Wang X. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 2012, 148:213-227.
26. Thapa R.J., Nogusa S., Chen P., Maki J.L., Lerro A., Andrake M., Rall G.F., Degterev A., Balachandran S. Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases. Proc Natl Acad Sci U S A 2013, 110:E3109-3118.
27. Ullah N., Naseer M.I., Ullah I., Lee H.Y., Koh P.O., Kim M.O. Protective effect of pyruvate against ethanol-induced apoptotic neurodegeneration in the developing rat brain. Neuropharmacology 2011, 61:1248-1255.
28. Wang Z.Y., Wei X.B., Chen L., Liu P., Wang L.X., Zhang B., Sun X., Zhang X.M. Neuroprotective effects of hydroxyethylpuerarin against focal cerebral ischemia-reperfusion in rats. Chin J Physiol 2007, 50:211-216.
29. Wang Y., Gu J., Wang J., Feng X., Tao Y., Jiang B., He J., Wang Q., Yang J., Zhang S., Cai J., Sun Y. BDNF and NT-3 expression by using glucocorticoid-induced bicistronic expression vector pGC-BDNF-IRES-NT3 protects apoptotic cells in a cellular injury model. Brain Res 2012, 1448:137-143.
30. Wang Y., Gu J., Feng X., Wang H., Tao Y., Wang J. Effects of Nogo-A receptor antagonist on the regulation of the Wnt signaling pathway and neural cell proliferation in newborn rats with hypoxic ischemic encephalopathy. Mol Med Rep 2013, 8:883-886.
31. Xu M., Zhang H.L. Death and survival of neuronal and astrocytic cells in ischemic brain injury: a role of autophagy. Acta Pharmacol Sin 2011, 32:1089-1099.
32. Xu X., Chua K.W., Chua C.C., Liu C.F., Hamdy R.C., Chua B.H. Synergistic protective effects of humanin and necrostatin-1 on hypoxia and ischemia/reperfusion injury. Brain Res 2010, 1355:189-194.
33. Zhang Q.L., Niu Q., Ji X.L., Conti P., Boscolo P. Is necroptosis a death pathway in aluminum-induced neuroblastoma cell demise?. Int J Immunopathol Pharmacol 2008, 21:787-796.